BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25586527)

  • 1. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
    LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
    Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
    LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
    J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and anorexia/cachexia in lung cancer: validation of the Spanish version of the FAACT instrument.
    Arrieta O; Luvián-Morales J; Turcott JG; Oñate-Ocaña LF
    Qual Life Res; 2018 Oct; 27(10):2709-2718. PubMed ID: 29987501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.
    Zhou T; Yang K; Thapa S; Fu Q; Jiang Y; Yu S
    Support Care Cancer; 2017 Apr; 25(4):1183-1189. PubMed ID: 27900546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the functional assessment of anorexia/cachexia therapy instrument to assess quality of life in maintenance hemodialysis patients with cachexia.
    Yang Z; Luo Y; Lu H; Zou B; Wang H; Chen G; Wu Y; Huang Y
    Semin Dial; 2022 Jul; 35(4):330-336. PubMed ID: 35032061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
    Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
    Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients.
    Turcott JG; Oñate-Ocaña LF; Soca-Chafre G; Ramírez-Tirado LA; Flores-Estrada D; Zatarain-Barrón ZL; Arrieta O
    Nutr Cancer; 2019; 71(3):409-417. PubMed ID: 30273069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
    Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
    Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.
    Blauwhoff-Buskermolen S; Ruijgrok C; Ostelo RW; de Vet HCW; Verheul HMW; de van der Schueren MAE; Langius JAE
    Support Care Cancer; 2016 Feb; 24(2):661-666. PubMed ID: 26160463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.
    Meregaglia M; Borsoi L; Cairns J; Tarricone R
    Eur J Health Econ; 2019 Mar; 20(2):181-193. PubMed ID: 28948436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review.
    Tarricone R; Ricca G; Nyanzi-Wakholi B; Medina-Lara A
    Crit Rev Oncol Hematol; 2016 Mar; 99():49-62. PubMed ID: 26775729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
    Chang VT; Xia Q; Kasimis B
    J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
    Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
    Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging a Team Mental Model to Develop a Cancer Anorexia-Cachexia Syndrome Team.
    Portman DG; Thirlwell S; Donovan KA; Alvero C; Gray JE; Holloway R; Ellington L
    J Oncol Pract; 2016 Nov; 12(11):1046-1052. PubMed ID: 27858539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
    Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
    Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of questionnaires for eating-related distress among advanced cancer patients and families.
    Amano K; Morita T; Miura T; Mori N; Tatara R; Kessoku T; Matsuda Y; Tagami K; Otani H; Mori M; Taniyama T; Nakajima N; Nakanishi E; Kako J; Ishiki H; Matsuoka H; Satomi E; Hopkinson JB; Baracos VE; Miyashita M
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):310-325. PubMed ID: 36403291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cancer anorexia-cachexia syndrome: myth or reality?
    Lasheen W; Walsh D
    Support Care Cancer; 2010 Feb; 18(2):265-72. PubMed ID: 19937260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer].
    Kosacka M; Weryńska B; Gołecki M; Jankowska R; Passowicz-Muszyńska E
    Pneumonol Alergol Pol; 2008; 76(5):360-5. PubMed ID: 19003767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer anorexia-cachexia syndrome is characterized by more than one inflammatory pathway.
    Gagnon B; Murphy J; Simonyan D; Penafuerte CA; Sirois J; Chasen M; Tremblay ML
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1041-1053. PubMed ID: 38481033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.